Conghua Xie
0000-0001-6623-9864
Publication & Citation Trends
Most Cited Works
Publications
409 total
Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial PDF
Cited by 112
OpenAlex
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial PDF
Cited by 551
OpenAlex
USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy PDF
Cited by 145
OpenAlex
Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review) PDF
Cited by 302
OpenAlex
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China PDF
Cited by 1,075
OpenAlex
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group PDF
Cited by 717
OpenAlex
Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11) PDF
Cited by 383
OpenAlex
SARS-CoV-2 transmission in cancer patients of a tertiary hospital in Wuhan PDF
Cited by 108
OpenAlex
Research Topics
Lung Cancer Treatments and Mutations
(49)
Lung Cancer Research Studies
(46)
Cancer Immunotherapy and Biomarkers
(38)
Head and Neck Cancer Studies
(32)
RNA modifications and cancer
(32)
Frequent Co-Authors
Affiliations
Academy of Medical Sciences
Loyola University Medical Center
Cleveland Clinic
University Health Network
Guangxi University